T. Rowe Price Associates’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $827K | Buy |
|
|||||
|
2025
Q1 | $997K | Buy |
|
|||||
|
2024
Q4 | $1.51M | Sell |
|
|||||
|
2024
Q3 | $6.38M | Sell |
|
|||||
|
2024
Q2 | $8.16M | Sell |
|
|||||
|
2024
Q1 | $10.1M | Buy |
|
|||||
|
2023
Q4 | $10.4M | Buy |
|
|||||
|
2023
Q3 | $7.31M | Buy |
|
|||||
|
2023
Q2 | $9.37M | Buy |
|
|||||
|
2023
Q1 | $5.74M | Buy |
|
|||||
|
2022
Q4 | $3.03M | Sell |
|
|||||
|
2022
Q3 | $6.27M | Sell |
|
|||||
|
2022
Q2 | $12.8M | Buy |
|
|||||
|
2022
Q1 | $19M | Buy |
|
|||||
|
2021
Q4 | $52.9M | Sell |
|
|||||
|
2021
Q3 | $74.8M | Sell |
|
|||||
|
2021
Q2 | $70.4M | Buy |
|
|||||
|
2021
Q1 | $74.9M | Buy |
|
|||||
|
2020
Q4 | $73.3M | Buy |
|
|||||
|
2020
Q3 | $42.4M | Buy |
|
|||||
|
2020
Q2 | $31.4M | Buy |
|
|||||
|
2020
Q1 | $25.9M | Buy |
|
|||||
|
2019
Q4 | $1.69M | Buy |
|
|||||
|
2019
Q3 | $363K | Buy |
|
|||||
|
2019
Q2 | $404K | Buy |
|
|||||
|
2019
Q1 | $232K | Buy |
|
|||||
|
2018
Q4 | $137K | Buy |
|
|||||
|
2018
Q3 | $165K | Buy |
|
|||||
|
2018
Q2 | $135K | Buy |
|
|||||
|
2018
Q1 | $84K | Buy |
|
|||||
|
2017
Q4 | $90K | Sell |
|
|||||
|
2017
Q3 | $164K | Hold |
|
|||||
|
2017
Q2 | $132K | Buy |
|
|||||
|
2017
Q1 | $100K | Buy |
|